A multicentre, case-control study was conducted to assess risk factors and patient outcomes of bacteraemia caused by Enterobacteriaceae producing extended-spectrum b-lactamases (ESBLs) and Klebsiella pneumoniae carbapenemases (KPCs). One hundred and five and 20 patients with bacteraemia caused by ESBL-producing and KPC-producing organisms were matched to controls who had bacteraemia caused by non-ESBL/KPC-producing organisms, respectively. Independent risk factors for ESBL production included admission from a nursing home (OR 4.64; 95% CI 2.64-8.16), chronic renal failure (OR 2.09; 95% CI 1.11-3.92), the presence of a gastrostomy tube (OR 3.36; 95% CI 1.38-8.18), length of hospital stay before infection (OR 1.02; 95% CI 1.01-1.03), transplant receipt (OR 2.48; 95% CI 1.24-4.95), and receipt of antibiotics with Gram-negative activity in the preceding 30 days (OR 1.76; 95% CI 1.00-3.08).
Introduction
Extended-spectrum b-lactamases (ESBLs) are now well recognized as a major cause of cephalosporin resistance among Enterobacteriaceae [1, 2] . Two important changes in the epidemiology of ESBLs have occurred in the last decade. One is the rapid global dissemination of Escherichia coli
Patients and Methods

Study design and patients
This multicentre, retrospective case-control study was conducted at three medical centres in the northeastern USA (New York, Massachusetts, and Pennsylvania) between 2005 and 2008. Patients with blood cultures growing E. coli, K. pneumoniae, Klebsiella oxytoca, Enterobacter cloacae and Enterobacter aerogenes were included. The two case groups consisted of those caused by ESBL-producing and KPC-producing organisms. Controls were selected so that each study site and species occurred in similar proportions in both cases and controls, with a ratio of three controls per case. The entire control group was used for the ESBL analysis, whereas only cases caused by K. pneumoniae were included in the KPC analysis, as all KPC-producing organisms belonged to this species. Only the first episode of bacteraemia was included for each patient. The study was approved by the Institutional Review Board at each participating site.
Risk factor analyses
The variables reviewed for risk factor analyses included demographic data, admission from a nursing home, prior use of antibiotics with Gram-negative activity in the preceding 30 days, presence of tracheostomy tube, gastrostomy tube, intravenous line or urinary catheter at the time of infection, prior hospitalization, length of hospital stay before the onset of bacteraemia, intensive-care unit (ICU) admission, surgery, outpatient intravenous therapy or dialysis in the preceding 1 year, diabetes, the presence of chronic renal failure, liver disease, chronic obstructive pulmonary disease, cardiovascular disease, peripheral vascular disease, cerebrovascular disease, peptic ulcer disease, malignancy and history of organ transplant. The Apache II score was also collected and included in the univariate analysis, but was not included in the multivariate analysis because it could not be defined for >10% of the cases. Immunocompromised state was defined as the presence of diabetes mellitus, neutropenia, human immunodeficiency virus infection, or receipt of steroids or other immunosuppressive agents in the 30 days prior to infection.
Predictors of mortality
The primary outcome measure was death within 28 days from the onset of bacteraemia. Predictors of 28-day mortality were analysed for the whole study population, as well as within the ESBL or KPC cases and the controls separately. Patients for whom 28-day status was unknown were excluded from the mortality analyses (n = 61). The parameters reviewed in addition to those used for risk factor analyses were inadequate empirical therapy, defined as receipt of empirical antibiotics with no in vitro activity against the infecting organism, ICU stay at the time of infection, source of bacteraemia, and Apache II score.
Microbiological methods
All E. coli and Klebsiella isolates that were reported as ESBL producers were subjected to PCR analyses to identify the presence of TEM-type, SHV-type and CTX-M-type b-lactamase genes [8] . Positive PCR results were followed by sequencing of the amplified products. For Enterobacter spp., all piperacillin-resistant or ceftriaxone-non-susceptible Enterobacter isolates were subjected to PCR analyses for the ESBL genes and sequencing [9] . For all species, ceftriaxonenon-susceptible isolates (corresponding to MICs ‡16 mg/L) underwent PCR analysis for detection of the KPC gene [10] .
Statistical analyses
Statistical analyses were performed with SAS version 9.2 (SAS Institute, Cary, NC, USA). For univariate analysis of risk factors and predictors of mortality, univariate logistic regression was performed. To identify independent risk factors and predictors of mortality, variables with a p-value £0.15 on univariate analysis were included in a stepwise conditional multivariate logistic regression model. All p-values were twotailed, and a p-value £0.05 was considered to be statistically significant.
Results
Demographics of the cohorts
A total of 450 patients with bacteraemia caused by Enterobacteriaceae (E. coli, Klebsiella spp., and Enterobacter spp.) were included. One hundred and twenty-five bacteraemia cases were caused by ESBL-producing or KPC-producing organisms, including E. coli (n = 32), Klebsiella spp. (n = 76), and Enterobacter spp. (n = 17). Of these, 20 cases were caused by KPC-producing K. pneumoniae, all of which were from the study site in New York City. The remaining 105 cases constituted the ESBL group. A total of 325 control cases were selected for analysis of the ESBL group. For analysis of the KPC group, K. pneumoniae cases from this control group were assigned (n = 176). The characteristics of these patients relative to ESBL and KPC status are shown in Tables 1 and 2, respectively. In the analysis of the ESBL and control groups, there was no significant difference in the proportion of patients >60 years of age, sex or race between the cases and controls ( Table 1 ). In the analysis of the KPC and control groups, there were significantly fewer Caucasian patients in the KPC group, reflecting the predominance of African American patients at the study site in New York City, where all of the KPC cases were identified ( Table 2 ).
Risk factors for ESBL production
Independent risk factors for bacteraemia caused by ESBLproducing organisms, after adjustment for potential confounding variables, included admission from a nursing home (OR 4.64; 95% CI 2.64-8.16, p <0.0001), chronic renal failure (OR 2.09; 95% CI 1.11-3.92, p 0.0223), the presence of a gastrostomy tube (OR 3.36; 95% CI 1.38-8.18, p 0.0076), length of hospital stay before infection (OR 1.02; 95% CI 1.01-1.03, p 0.0015), history of transplant (OR 2.48; 95% CI 1.24-4.95, p 0.0103), and receipt of antibiotics with Gram-negative activity in the preceding 30 days (OR 1.76; 95% CI 1.00-3.08, p 0.0491) ( Table 1 ).
For further characterization of the association between prior antibiotic exposure and ESBL-producing organisms, the antibiotics were divided into classes and assessed for their association. We observed that prior use of cefepime and carbapenems was significantly associated with infection with an ESBL-producing organism in the univariate analysis, but the significance did not remain in the multivariate analysis (Table 1) .
Risk factors for KPC production
Owing to the relatively small number of KPC cases, multivariate analysis was deferred for this comparison. In the univariate analysis, significant risk factors were largely consistent with those observed with the ESBL group, with the exception of surgery in the past year ( Table 2) . Regarding the individual antibiotic classes, receipt of carbapenems, cefepime or ceftriaxone in the prior 30 days was associated with infection with a KPC-producing organism. 
Predictors of mortality
Predictors of mortality were first assessed for the whole study population. The results from univariate and multivariate analyses are shown in Table 3 ). Production of ESBL or KPC was a significant predictor of mortality in the univariate analysis but was not a predictor after adjustment for other confounding variables in the multivariate analysis.
The predictors of mortality were then assessed for the ESBL group. Inadequate empirical therapy (OR 6.30; 95% CI 1.64-24.3; p 0.007) and Apache II score (OR 1.14; 
Discussion
The emergence and spread of CTX-M-type ESBLs and KPC-type carbapenemases are the two major developments in b-lactam resistance that have taken place in the last decade. CTX-M-type ESBLs became the predominant ESBLs in E. coli in many parts of the world by the early 2000s [3] . Although they were initially considered to be rare, recent reports indicate that CTX-M-type ESBLs are becoming more common in the USA as well, especially in E. coli [4] . KPC-type carbapenemases rapidly spread among K. pneumoniae strains, which have caused nosocomial outbreaks in hospitals throughout the east coast of the USA [7] . Studies from the USA that have addressed the clinical characteristics of bacteraemia caused by ESBL-producing Enterobacteriaceae were conducted either before the advent of these newer b-lactamases or without molecular characterization [2, 11] . The present study was thus undertaken to identify the clinical features of bacteraemia caused by ESBL-producing and KPC-producing Enterobacteriaceae in a contemporary cohort of patients from tertiary hospitals in the northeastern USA.
Our results indicate that CTX-M-type ESBLs are now common among bacteraemic isolates of Enterobactericeae in this geographical area. Among E. coli, the majority had this group of ESBLs. About half of them had CTX-M-15, which is increasingly recognized as the most common CTX-Mtype ESBL in many parts of the world [12] , but the CTX-M-2 and CTX-M-9 groups, which are known to predominate in South America and Spain, respectively, were also present [3] . SHV-type and TEM-type ESBLs constituted the rest, although they were much less common than CTX-Mtype ESBLs. This trend was also reported in a recent study of ESBL-producing E. coli conducted in Philadelphia [13] . Taking these findings together, we may assume that CTX-M-type ESBLs are now prevalent in this species in the northeastern USA. In Klebsiella spp. and Enterobacter spp., SHV was still the most common ESBL type, but CTX-Mtype ESBLs were also present in both organisms. All 20 KPC-producing organisms were from the study site in New York City, where they are known to be endemic [14] .
The 28-day mortality rate of patients with bacteraemia caused by organisms producing ESBL or KPC was significantly higher, at 29.1%, than in the control group, at 19.5%. This is in line with the results of a recent meta-analysis that pooled data from 16 studies and showed a significantly increased mortality rate for ESBL-associated bacteraemia [1] . The subset of patients with KPC-producing K. pneumoniae in our study had an even higher mortality rate, at 47.4%, as opposed to 27.5% for those with ESBL-producing K. pneumoniae. Although the difference was not statistically significant, probably because of the relatively small number of patients, our data strengthen the previously reported association between KPC-producing K. pneumoniae bacteraemia and increased mortality [14] .
The independent risk factors for ESBL-associated bacteraemia included recent antibiotic use, admission from a nursing home, length of hospital stay prior to infection, chronic renal failure, presence of a gastrostomy tube, and history of transplant. Recent antibiotic use has been pointed out as an independent risk factor in multiple studies that have investigated ESBL-associated bacteraemia [11, [15] [16] [17] [18] . Admission from a nursing home has also been identified as a risk factor for ESBL production in several studies investigating bacteraemia [19] [20] [21] . The presence of a gastrostomy tube has been associated with acquisition of ESBL-producing organisms among nursing home residents [22, 23] , whereas chronic renal failure has not been associated with acquisition of ESBL-producing organisms.
Independent risk factors for mortality in the ESBL group included higher Apache II score at the time of positive blood culture and inappropriate empirical therapy. The association of higher Apache II score with increased mortality is not surprising and this was an independent risk factor for mortality in control cases as well. Inappropriate empirical therapy, defined by the use of antibiotic(s) that lack in vitro activity against the causative organism, has been identified as independent risk factor for death in ESBL-associated bacteraemia in several studies [24, 25] . We may therefore speculate that the significantly increased mortality with inappropriate empirical therapy, which occurred more frequently in the ESBL and KPC groups than in the control group, contributed to the excess mortality.
Our study has several limitations. First, we analysed ESBLproducing Enterobacteriaceae together, not by species. The selection of controls to be in the same proportions by species as the cases helped to address some of the potential bias arising from this. Second, our analysis of the KPC cases was limited, owing to the relatively small number of cases. Finally, we were not able to associate types of ESBL with clinical attributes, because of their heterogeneity.
In conclusion, mortality associated with bacteraemia caused by ESBL-producing or KPC-producing Enterobacteriaceae continues to be high, despite improved detection in the clinical laboratory. CTX-M-type ESBLs are now common in E. coli and are also present in other species in the northeastern USA. The frequent occurrence of delay in appropriate therapy probably contributes to the excess mortality. The use of antimicrobials with activity against ESBL-producing organisms, such as carbapenems, is generally accepted as appropriate in unwell patients with risk factors. However, the advent of K. pneumoniae producing KPC-type carbapenemase further complicates this issue.
